Mphasis Q1 FY27 Results Analysis: Revenue Surges 17.5%, TCV Hits USD 461M

Mphasis Ltd's Q1 FY27 numbers came in mixed, with revenue of Rs. 4,384.05 Cr (+17.46% YoY) and PAT growth of +10.82% YoY. Here's a quick read of what worked, what to watch, and what management said.

Quarter Snapshot

Mphasis delivered 17.5% YoY revenue growth with strong TCV of USD 461M and a TMT segment surge, but margin compression from rising other expenses and a sharp drop in subsidiary profitability due to the TAP acquisition loss weighed on earnings. The EBIT margin remained within the guided band, and management expects sequential growth acceleration in Q2.

Key Investment Insights

Key Positives

• Revenue grew 17.46% YoY to Rs.4,384.05 Cr, with constant-currency growth of 2.1% QoQ.
• TCV deal wins of USD 461 million provide strong pipeline visibility.
• TMT segment revenue surged 17.85% QoQ and 20.23% YoY, with segment margin expanding 904 bps QoQ to 25.99%.
• Employee cost leverage improved 251 bps YoY (employee cost as % of revenue dropped from 57.45% to 54.94%).
• Standalone PAT surged 54% YoY.

Risk Factors

• EBITDA margin contracted 68 bps YoY to 18.15%, driven by other expenses growing 33.33% YoY.
• Insurance segment margin collapsed from 34.93% to 12.87% YoY, dragging consolidated profitability.
• Subsidiary contribution dropped 79% YoY (from Rs.143.52 Cr to Rs.30.29 Cr) largely due to TAP acquisition loss of Rs.149.50M.
• Effective tax rate rose to 28.31% from 27.60% YoY, the highest in the period series.